The Environmental Working Group's 2017 guide steers consumers toward mineral-based formulas due to purported risks associated with chemical actives, while Consumer Reports says mineral sunscreens are most likely to carry inflated SPF claims. Online chatter shows that consumers are understandably at a loss.
The Environmental Working Group continues to rank mineral-based sunscreens more highly in its annual Guide to Sunscreens due to cited chemical filter risks – and concerns about oxybenzone specifically – that industry maintains are bunk.
"Most non-mineral sunscreens score poorly in EWG’s sunscreen guide because they include potentially toxic additives, including oxybenzone, an endocrine-disrupting chemical, or retinyl palmitate, an antioxidant additive that might damage sun-exposed...
Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”
An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.
Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.
France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.
Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.
Some changes the administration has proposed are a “great example of regulating by press release,” says Duffy MacKay, CHPA’s dietary supplements chief. But “after 30 years, the Dietary Supplement Health and Education Act could be modernized to serve the consumer better.”
Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.
